Request Discount

Epinephrine Autoinjector Market (Dosage - 0.15 Mg Epinephrine Autoinjector, 0.3 Mg Epinephrine Autoinjector, and 0.5 Mg Epinephrine Autoinjector; End-user - Hospital, Clinics, and Individual): Global Industry Analysis, Trends, Size, Share and Forecasts to 2028

  • Published : July, 2022

  • Rep Id : HC0901

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on the epinephrine autoinjector market provides in-depth analysis of segments and sub-segments in the global as well as regional epinephrine autoinjector market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional epinephrine autoinjector market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global epinephrine autoinjector market. According to the report, the global epinephrine autoinjector market is projected to grow at a CAGR of nearly 8% over the forecast period of 2022-2028.

 

Market Insight

The Global Epinephrine Autoinjector Market was valued at over USD 2 Billion in 2022 and is expected to reach nearly USD 3.5 Billion in 2028, with a CAGR of nearly 8% during the forecast period. Epinephrine autoinjectors are known as hand-held medical devices utilized by patients who have severe allergies. Epinephrine injections are particularly utilized to treat the life-threatening allergic reactions caused by insect bites, medications, or stings. Epinephrine injections are available as prefilled automatic injection devices with the hormone in liquid form. An increasing number of patient-support efforts and innovative product development by major market players will provide lucrative growth opportunities for the market. The growing demand for epinephrine auto-injectors for rapid emergency response is projected to propel market growth. The key element driving the epinephrine auto-injector market growth in the high dosage sector is the rising incidence of anaphylaxis in adults, particularly among the old population.

 

The key factors supporting the growth of the epinephrine autoinjectors involves the demand for autoinjectors instead of conventional syringes, increasing prevalence of allergies, and increased focus of the major market players on the development of chlorofluorocarbon free epinephrine injectors during the forecast period. The rising incidence and awareness of allergies in the population is also increasing the demand of the autoinjector. Technological advancements in Research and Development activities such as chlorofluorocarbon-free epinephrine auto-injector inhalers with the use of hydrofluoroalkane propellants will drive expansion of the market. Furthermore, high demand for auto-injectors rather than conventional devices such as typical epinephrine auto-injector inhalers are subsidizing the growth of the Market during the forecast period. However, a high cost of autoinjectors and regulatory hurdles can hinder the epinephrine growth during the forecast period. Moreover, Patient’s assistance programs carried out for an uninsured person, continuous product modification and demand for automatic injection devices to further create growth opportunities for the epinephrine autoinjector market.

 

The COVID-19 pandemic had mixed effects on the worldwide epinephrine autoinjector market during the covid-19 pandemic. Most non-essential procedures and in-hospital therapies were deferred within the half of 2020 to forestall the spread of the infection and ease the toll on healthcare infrastructure. consistent with researchers at Indiana University, healthcare visits decreased by around 40% within the first six weeks of the pandemic in the US, from early March to mid-April. However, the pandemic’s overall effect on the autoinjectors is known as positive, especially within the forecast period, because of several factors. Firstly, the demand for effective home care and remote monitoring has increased the relevance of autoinjectors for patients to conveniently and simply manage chronic illnesses and allergies without visiting the hospital.

 

The global epinephrine autoinjector market is segmented into the Asia Pacific, North America, Europe, the Middle East & Africa, and South America. On the basis of region, North America has the largest market share in the epinephrine autoinjector market on account of improved healthcare infrastructure, and the adoption of high-cost autoinjector rather in contrast to conventional injecting methods. Asia Pacific is expected to grow at the highest CAGR over the forecast period Because of the increasing number of people afflicted with various allergies and increasing awareness about epinephrine autoinjectors among the population. Moreover, increasing investment in the development of new advanced autoinjectors by major market players is projected to enhance the growth during the forecast period.

 

Segment Covered

The report on global epinephrine autoinjector market covers segments such as dosage, and end-user. On the basis of dosage, the sub-markets include 0.15 mg epinephrine autoinjector, 0.3 mg epinephrine autoinjector, and 0.5 mg epinephrine autoinjector. On the basis of end-user, the sub-markets include hospital, clinics, and individual.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Pfizer Inc., Mylan Inc., ALK Abello, Sanofi SA, Lincoln Medical Ltd, Teva Pharmaceuticals Ltd, Antares Pharma Inc., Lincoln Medical Ltd., Impax Laboratories, Inc., and Bausch & Lomb Incorporated.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of epinephrine autoinjector market. Moreover, the study highlights current market trends and provides forecast from 2022-2028. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount